Plasma xanthine oxidoreductase (XOR) activity in patients who require cardiovascular intensive care

Hyperuricemia is known to be associated with adverse outcomes in cardiovascular intensive care patients, but its mechanisms are unknown. A total of 569 emergency department patients were prospectively analyzed and assigned to intensive care (ICU group, n = 431) or other departments ( n = 138). Uri...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Heart and vessels 2020-10, Vol.35 (10), p.1390-1400
Hauptverfasser:	Shibata, Yusaku, Shirakabe, Akihiro, Okazaki, Hirotake, Matsushita, Masato, Goda, Hiroki, Shigihara, Shota, Asano, Kazuhiro, Kiuchi, Kazutaka, Tani, Kenichi, Murase, Takayo, Nakamura, Takashi, Kobayashi, Nobuaki, Hata, Noritake, Asai, Kuniya, Shimizu, Wataru
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over APACHE Biomarkers - blood Biomedical Engineering and Bioengineering Cardiac Surgery Cardiology Cardiovascular Diseases - blood Cardiovascular Diseases - diagnosis Cardiovascular Diseases - mortality Cardiovascular Diseases - therapy Emergency medical care Emergency medical services Emergency Service, Hospital Female Hospital Mortality Humans Hyperuricemia Hyperuricemia - blood Hyperuricemia - diagnosis Hyperuricemia - mortality Hyperuricemia - therapy Intensive care Intensive Care Units Lactic acid Male Medicine Medicine & Public Health Middle Aged Mortality Original Article Plasma Prognosis Prospective Studies Quartiles Regression analysis Regression models Risk Assessment Risk Factors Up-Regulation Uric acid Uric Acid - blood Vascular Surgery Xanthine Dehydrogenase - blood Xanthine oxidoreductase
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!